Kemwell Pharma
Bengaluru, India kemwellbiopharma.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Kemwell Pharma is a biologics CDMO based in Bangalore, India, serving global pharmaceutical and biotech organizations. It provides integrated development and manufacturing for mammalian cell-culture-based protein therapeutics, including drug substance and drug product, for clinical and commercial supply.
Services
Biologics Development
Integrated development services for mammalian cell-culture-based protein therapeutics from cell line development through cGMP clinical and commercial manufacturing.
Process Development
High-throughput upstream and downstream process development for mammalian cell-culture-based protein therapeutics, including process optimization and characterization.
Formulation Development
Pre-formulation studies, formulation screening studies, and lyophilization cycle development.
Analytical Development
Method development, qualification, and validation, including platform methodologies.
Biologics cGMP Manufacturing
Integrated cGMP manufacturing services for drug substance and drug product, including clinical and commercial manufacturing.
Drug Substance cGMP Manufacturing
Manufacturing of biologic drug substance at clinical and commercial scale.
Drug Product cGMP Manufacturing
Manufacturing of liquid and lyophilized drug product, including fill-finish.
Quality Control and Quality Assurance
Quality functions supporting QC activities, GMP activities, batch release, and controlled-area monitoring.
1 more services
- Integrated Services
Capabilities
- Assays and studies
- Analytical development
- Process development
- Stability studies
- Antibodies
- Bispecifics
- HPLC
9 more
- Fill-finish
- Bioreactors
- Lyophilization
- In vitro bioassay
- Sterility testing
- Endotoxin testing
- Analytical method development
- Analytical method qualification
- Analytical method validation
- Scale and capacity
- SS 80L-400L-2x2000L
- SUB 200L, 1000L
- Up to 2000L scale
- Over 5000L installed upstream capacity
- 20+ batches per annum
- Provision to add up to 12000L bioreactor capacity
- Therapeutic areas
- Biologics
- Protein therapeutics
Instruments and platforms
- AMBR®250
- Bausch+Ströbel vial filling line
- Lyophilizer
- Continuous centrifugation
- Lenticular filtration
- HPLC tracking system
3 more
- LIMS
- SAP
- EMPOWER server system
Modalities and species
- Modalities
- Antibody
- Bispecific
- Cell therapy
- Recombinant protein
- Biosimilar
- Species and models
- Mammalian cell-culture
- AMBR®250
- Shake flasks
- 5L glass bioreactors
- 10L glass bioreactors
- 50L single-use bioreactors
5 more
- 80L stainless-steel bioreactors
- 200L single-use bioreactors
- 400L stainless-steel bioreactors
- 1000L single-use bioreactors
- 2x2000L stainless-steel bioreactors
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
GLPSelf-reported
Details
- Type
- CRDMO
- Founded
- 2012
- Office
- Manufacturing 2021 Established cGMP Cell therapy manufacturing facility in col
- Sites
- Bangalore, India
- Serves
- US, APAC, ROW, CIS, MENA